Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Nancy You

Showing results (171-180 of 197) with videos related to

Pageof 20
Sort By:
Cancer|October 4, 2013
Quantified pathologic response assessed as residual tumor burden is a predictor of recurrence-free survival in patients with rectal cancer who undergo resection after neoadjuvant chemoradiotherapyAtin Agarwal, George J Chang, Chung-Yuan Hu, et al.
Familial Cancer|June 26, 2019
Energy balance related lifestyle factors and risk of endometrial and colorectal cancer among individuals with lynch syndrome: a systematic reviewAdriana M Coletta, Susan K Peterson, Leticia A Gatus, et al.
International Journal of Radiation Oncology, Biology, Physics|December 10, 2013
Preoperative radiation therapy with concurrent capecitabine, bevacizumab, and erlotinib for rectal cancer: a phase 1 trialPrajnan Das, Cathy Eng, Miguel A Rodriguez-Bigas, et al.
Clinical Colorectal Cancer|March 6, 2023
Patient-reported Bowel Function and Bowel-related Quality of Life After Pelvic Radiation for Rectal Adenocarcinoma: The Impact of Radiation Fractionation and Surgical ResectionMichael K Rooney, Brian De, Kelsey Corrigan, et al.
Frontiers in Oncology|May 11, 2023
Colorectal surveillance outcomes from an institutional longitudinal cohort of lynch syndrome carriersGabriel Del Carmen, Laura Reyes-Uribe, Daniel Goyco, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|January 6, 2025
Mutational and co-mutational landscape of early onset colorectal cancerJumanah Yousef Alshenaifi, Guglielmo Vetere, Giulia Maddalena, et al.
Nature Communications|April 3, 2026
Genomic analysis of T Cell receptors reveals lynch syndrome specific immune signaturesNan Deng, Fahriye Duzagac, Ana M Bolivar, et al.
JCO Oncology Practice|May 31, 2026
Impact of Dedicated Care Coordination on Access to Multidimensional Support Services in Young-Onset Colorectal Cancer: A Pragmatic TrialJeongyoon Moon, Elaine Maghanoy, Victoria S Higbie, et al.
JNCI Cancer Spectrum|January 15, 2025
Rethinking the rise of early-onset gastrointestinal cancers: a call to actionBenjamin A Weinberg, Caitlin C Murphy, David R Freyer, et al.
International Journal of Radiation Oncology, Biology, Physics|May 19, 2022
Patient-Reported Bowel and Urinary Function in Long-Term Survivors of Squamous Cell Carcinoma of the Anus Treated With Definitive Intensity Modulated Radiation Therapy And Concurrent ChemotherapyBrian De, Kelsey L Corrigan, Michael K Rooney, et al.
Pageof 20

Showing results (171-180 of 197) with videos related to

Sort By:
Pageof 20
Cancer|October 4, 2013
Quantified pathologic response assessed as residual tumor burden is a predictor of recurrence-free survival in patients with rectal cancer who undergo resection after neoadjuvant chemoradiotherapyAtin Agarwal, George J Chang, Chung-Yuan Hu, et al.
Familial Cancer|June 26, 2019
Energy balance related lifestyle factors and risk of endometrial and colorectal cancer among individuals with lynch syndrome: a systematic reviewAdriana M Coletta, Susan K Peterson, Leticia A Gatus, et al.
International Journal of Radiation Oncology, Biology, Physics|December 10, 2013
Preoperative radiation therapy with concurrent capecitabine, bevacizumab, and erlotinib for rectal cancer: a phase 1 trialPrajnan Das, Cathy Eng, Miguel A Rodriguez-Bigas, et al.
Clinical Colorectal Cancer|March 6, 2023
Patient-reported Bowel Function and Bowel-related Quality of Life After Pelvic Radiation for Rectal Adenocarcinoma: The Impact of Radiation Fractionation and Surgical ResectionMichael K Rooney, Brian De, Kelsey Corrigan, et al.
Frontiers in Oncology|May 11, 2023
Colorectal surveillance outcomes from an institutional longitudinal cohort of lynch syndrome carriersGabriel Del Carmen, Laura Reyes-Uribe, Daniel Goyco, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|January 6, 2025
Mutational and co-mutational landscape of early onset colorectal cancerJumanah Yousef Alshenaifi, Guglielmo Vetere, Giulia Maddalena, et al.
Nature Communications|April 3, 2026
Genomic analysis of T Cell receptors reveals lynch syndrome specific immune signaturesNan Deng, Fahriye Duzagac, Ana M Bolivar, et al.
JCO Oncology Practice|May 31, 2026
Impact of Dedicated Care Coordination on Access to Multidimensional Support Services in Young-Onset Colorectal Cancer: A Pragmatic TrialJeongyoon Moon, Elaine Maghanoy, Victoria S Higbie, et al.
JNCI Cancer Spectrum|January 15, 2025
Rethinking the rise of early-onset gastrointestinal cancers: a call to actionBenjamin A Weinberg, Caitlin C Murphy, David R Freyer, et al.
International Journal of Radiation Oncology, Biology, Physics|May 19, 2022
Patient-Reported Bowel and Urinary Function in Long-Term Survivors of Squamous Cell Carcinoma of the Anus Treated With Definitive Intensity Modulated Radiation Therapy And Concurrent ChemotherapyBrian De, Kelsey L Corrigan, Michael K Rooney, et al.
Pageof 20